nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2D6—breast cancer	0.0996	0.538	CbGaD
Carbinoxamine—CYP3A4—breast cancer	0.0854	0.462	CbGaD
Carbinoxamine—Cloperastine—Raloxifene—breast cancer	0.0583	0.169	CrCrCtD
Carbinoxamine—Doxylamine—Toremifene—breast cancer	0.0425	0.123	CrCrCtD
Carbinoxamine—Bromodiphenhydramine—Toremifene—breast cancer	0.036	0.104	CrCrCtD
Carbinoxamine—Clofedanol—Toremifene—breast cancer	0.0292	0.0848	CrCrCtD
Carbinoxamine—Orphenadrine—Toremifene—breast cancer	0.0283	0.082	CrCrCtD
Carbinoxamine—Doxylamine—Tamoxifen—breast cancer	0.0267	0.0775	CrCrCtD
Carbinoxamine—CYP2B6—Thiotepa—breast cancer	0.0253	0.0732	CbGbCtD
Carbinoxamine—Diphenhydramine—Toremifene—breast cancer	0.0251	0.0728	CrCrCtD
Carbinoxamine—Tripelennamine—Tamoxifen—breast cancer	0.0242	0.0701	CrCrCtD
Carbinoxamine—Bromodiphenhydramine—Tamoxifen—breast cancer	0.0226	0.0655	CrCrCtD
Carbinoxamine—Clofedanol—Tamoxifen—breast cancer	0.0183	0.0532	CrCrCtD
Carbinoxamine—Orphenadrine—Tamoxifen—breast cancer	0.0177	0.0515	CrCrCtD
Carbinoxamine—CYP2C9—Anastrozole—breast cancer	0.0176	0.051	CbGbCtD
Carbinoxamine—CYP2B6—Raloxifene—breast cancer	0.0169	0.0488	CbGbCtD
Carbinoxamine—CYP2C8—Lapatinib—breast cancer	0.0169	0.0488	CbGbCtD
Carbinoxamine—Diphenhydramine—Tamoxifen—breast cancer	0.0158	0.0457	CrCrCtD
Carbinoxamine—CYP2C19—Lapatinib—breast cancer	0.0141	0.0409	CbGbCtD
Carbinoxamine—CYP3A4—Exemestane—breast cancer	0.0135	0.0391	CbGbCtD
Carbinoxamine—CYP2C9—Idarubicin—breast cancer	0.0134	0.0387	CbGbCtD
Carbinoxamine—CYP2C8—Raloxifene—breast cancer	0.0128	0.037	CbGbCtD
Carbinoxamine—CYP2D6—Idarubicin—breast cancer	0.0122	0.0354	CbGbCtD
Carbinoxamine—CYP3A4—Letrozole—breast cancer	0.0115	0.0333	CbGbCtD
Carbinoxamine—CYP2E1—Tamoxifen—breast cancer	0.0113	0.0327	CbGbCtD
Carbinoxamine—CYP2B6—Tamoxifen—breast cancer	0.0111	0.0323	CbGbCtD
Carbinoxamine—CYP2E1—Mitoxantrone—breast cancer	0.011	0.0319	CbGbCtD
Carbinoxamine—CYP3A4—Anastrozole—breast cancer	0.0102	0.0297	CbGbCtD
Carbinoxamine—CYP3A4—Toremifene—breast cancer	0.00937	0.0271	CbGbCtD
Carbinoxamine—CYP3A4—Fulvestrant—breast cancer	0.00871	0.0252	CbGbCtD
Carbinoxamine—CYP2B6—Irinotecan—breast cancer	0.00856	0.0248	CbGbCtD
Carbinoxamine—CYP2C8—Tamoxifen—breast cancer	0.00844	0.0244	CbGbCtD
Carbinoxamine—CYP3A4—Thiotepa—breast cancer	0.00777	0.0225	CbGbCtD
Carbinoxamine—CYP2C9—Capecitabine—breast cancer	0.00732	0.0212	CbGbCtD
Carbinoxamine—CYP3A4—Ixabepilone—breast cancer	0.0071	0.0206	CbGbCtD
Carbinoxamine—CYP2C19—Tamoxifen—breast cancer	0.00708	0.0205	CbGbCtD
Carbinoxamine—CYP3A4—Lapatinib—breast cancer	0.00684	0.0198	CbGbCtD
Carbinoxamine—CYP2C8—Paclitaxel—breast cancer	0.00657	0.019	CbGbCtD
Carbinoxamine—CYP2C8—Fluorouracil—breast cancer	0.00622	0.018	CbGbCtD
Carbinoxamine—CYP2D6—Vinorelbine—breast cancer	0.00596	0.0173	CbGbCtD
Carbinoxamine—CYP2C9—Tamoxifen—breast cancer	0.00589	0.017	CbGbCtD
Carbinoxamine—CYP2D6—Tamoxifen—breast cancer	0.00538	0.0156	CbGbCtD
Carbinoxamine—CYP3A4—Raloxifene—breast cancer	0.00518	0.015	CbGbCtD
Carbinoxamine—CYP2B6—Doxorubicin—breast cancer	0.00467	0.0135	CbGbCtD
Carbinoxamine—CYP2C9—Paclitaxel—breast cancer	0.00458	0.0133	CbGbCtD
Carbinoxamine—CYP2C9—Fluorouracil—breast cancer	0.00434	0.0126	CbGbCtD
Carbinoxamine—CYP3A4—Vinorelbine—breast cancer	0.00379	0.011	CbGbCtD
Carbinoxamine—CYP2D6—Vinblastine—breast cancer	0.00368	0.0106	CbGbCtD
Carbinoxamine—CYP3A4—Tamoxifen—breast cancer	0.00342	0.00991	CbGbCtD
Carbinoxamine—CYP3A4—Mitoxantrone—breast cancer	0.00334	0.00967	CbGbCtD
Carbinoxamine—CYP3A4—Paclitaxel—breast cancer	0.00266	0.00772	CbGbCtD
Carbinoxamine—CYP3A4—Irinotecan—breast cancer	0.00263	0.00761	CbGbCtD
Carbinoxamine—CYP3A4—Vinblastine—breast cancer	0.00234	0.00677	CbGbCtD
Carbinoxamine—CYP2D6—Doxorubicin—breast cancer	0.00226	0.00654	CbGbCtD
Carbinoxamine—CYP3A4—Docetaxel—breast cancer	0.00193	0.00558	CbGbCtD
Carbinoxamine—CYP3A4—Doxorubicin—breast cancer	0.00144	0.00416	CbGbCtD
Carbinoxamine—Mitotane—SHBG—breast cancer	0.0003	0.215	CrCbGaD
Carbinoxamine—Orphenadrine—SCN10A—breast cancer	0.000119	0.0849	CrCbGaD
Carbinoxamine—Clomipramine—GSTP1—breast cancer	0.000113	0.081	CrCbGaD
Carbinoxamine—Mepyramine—CYP2D6—breast cancer	0.000106	0.0755	CrCbGaD
Carbinoxamine—Tripelennamine—CYP2D6—breast cancer	9.76e-05	0.0699	CrCbGaD
Carbinoxamine—Diarrhoea—Goserelin—breast cancer	9.36e-05	0.0012	CcSEcCtD
Carbinoxamine—Urticaria—Thiotepa—breast cancer	9.3e-05	0.00119	CcSEcCtD
Carbinoxamine—Agitation—Paclitaxel—breast cancer	9.28e-05	0.00119	CcSEcCtD
Carbinoxamine—Headache—Vinblastine—breast cancer	9.24e-05	0.00118	CcSEcCtD
Carbinoxamine—Anorexia—Fluorouracil—breast cancer	9.23e-05	0.00118	CcSEcCtD
Carbinoxamine—Hypotension—Gemcitabine—breast cancer	9.2e-05	0.00118	CcSEcCtD
Carbinoxamine—Insomnia—Irinotecan—breast cancer	9.14e-05	0.00117	CcSEcCtD
Carbinoxamine—Vomiting—Tamoxifen—breast cancer	9.11e-05	0.00117	CcSEcCtD
Carbinoxamine—Paraesthesia—Irinotecan—breast cancer	9.08e-05	0.00116	CcSEcCtD
Carbinoxamine—Paraesthesia—Mitoxantrone—breast cancer	9.08e-05	0.00116	CcSEcCtD
Carbinoxamine—Vertigo—Paclitaxel—breast cancer	9.07e-05	0.00116	CcSEcCtD
Carbinoxamine—Dizziness—Goserelin—breast cancer	9.05e-05	0.00116	CcSEcCtD
Carbinoxamine—Hypotension—Fluorouracil—breast cancer	9.05e-05	0.00116	CcSEcCtD
Carbinoxamine—Somnolence—Mitoxantrone—breast cancer	8.99e-05	0.00115	CcSEcCtD
Carbinoxamine—Somnolence—Irinotecan—breast cancer	8.99e-05	0.00115	CcSEcCtD
Carbinoxamine—Headache—Tamoxifen—breast cancer	8.97e-05	0.00115	CcSEcCtD
Carbinoxamine—Palpitations—Paclitaxel—breast cancer	8.93e-05	0.00114	CcSEcCtD
Carbinoxamine—Vomiting—Melphalan—breast cancer	8.92e-05	0.00114	CcSEcCtD
Carbinoxamine—Insomnia—Gemcitabine—breast cancer	8.9e-05	0.00114	CcSEcCtD
Carbinoxamine—Dyspepsia—Irinotecan—breast cancer	8.9e-05	0.00114	CcSEcCtD
Carbinoxamine—Dyspepsia—Mitoxantrone—breast cancer	8.9e-05	0.00114	CcSEcCtD
Carbinoxamine—Tinnitus—Capecitabine—breast cancer	8.88e-05	0.00114	CcSEcCtD
Carbinoxamine—Diplopia—Doxorubicin—breast cancer	8.87e-05	0.00114	CcSEcCtD
Carbinoxamine—Paraesthesia—Gemcitabine—breast cancer	8.84e-05	0.00113	CcSEcCtD
Carbinoxamine—Chills—Docetaxel—breast cancer	8.82e-05	0.00113	CcSEcCtD
Carbinoxamine—Asthenia—Vinorelbine—breast cancer	8.79e-05	0.00113	CcSEcCtD
Carbinoxamine—Decreased appetite—Mitoxantrone—breast cancer	8.79e-05	0.00112	CcSEcCtD
Carbinoxamine—Decreased appetite—Irinotecan—breast cancer	8.79e-05	0.00112	CcSEcCtD
Carbinoxamine—Nausea—Vinblastine—breast cancer	8.76e-05	0.00112	CcSEcCtD
Carbinoxamine—Insomnia—Fluorouracil—breast cancer	8.76e-05	0.00112	CcSEcCtD
Carbinoxamine—Somnolence—Gemcitabine—breast cancer	8.75e-05	0.00112	CcSEcCtD
Carbinoxamine—Convulsion—Paclitaxel—breast cancer	8.75e-05	0.00112	CcSEcCtD
Carbinoxamine—Fatigue—Mitoxantrone—breast cancer	8.71e-05	0.00112	CcSEcCtD
Carbinoxamine—Fatigue—Irinotecan—breast cancer	8.71e-05	0.00112	CcSEcCtD
Carbinoxamine—Vomiting—Goserelin—breast cancer	8.7e-05	0.00111	CcSEcCtD
Carbinoxamine—Paraesthesia—Fluorouracil—breast cancer	8.69e-05	0.00111	CcSEcCtD
Carbinoxamine—Constipation—Mitoxantrone—breast cancer	8.64e-05	0.00111	CcSEcCtD
Carbinoxamine—Constipation—Irinotecan—breast cancer	8.64e-05	0.00111	CcSEcCtD
Carbinoxamine—Somnolence—Fluorouracil—breast cancer	8.61e-05	0.0011	CcSEcCtD
Carbinoxamine—Headache—Goserelin—breast cancer	8.57e-05	0.0011	CcSEcCtD
Carbinoxamine—Decreased appetite—Gemcitabine—breast cancer	8.56e-05	0.0011	CcSEcCtD
Carbinoxamine—Chills—Capecitabine—breast cancer	8.54e-05	0.00109	CcSEcCtD
Carbinoxamine—Dyspepsia—Fluorouracil—breast cancer	8.52e-05	0.00109	CcSEcCtD
Carbinoxamine—Nausea—Tamoxifen—breast cancer	8.51e-05	0.00109	CcSEcCtD
Carbinoxamine—Fatigue—Gemcitabine—breast cancer	8.49e-05	0.00109	CcSEcCtD
Carbinoxamine—Constipation—Gemcitabine—breast cancer	8.42e-05	0.00108	CcSEcCtD
Carbinoxamine—Decreased appetite—Fluorouracil—breast cancer	8.42e-05	0.00108	CcSEcCtD
Carbinoxamine—Asthenia—Thiotepa—breast cancer	8.4e-05	0.00108	CcSEcCtD
Carbinoxamine—Diarrhoea—Vinorelbine—breast cancer	8.39e-05	0.00107	CcSEcCtD
Carbinoxamine—Nausea—Melphalan—breast cancer	8.33e-05	0.00107	CcSEcCtD
Carbinoxamine—Feeling abnormal—Irinotecan—breast cancer	8.33e-05	0.00107	CcSEcCtD
Carbinoxamine—Feeling abnormal—Mitoxantrone—breast cancer	8.33e-05	0.00107	CcSEcCtD
Carbinoxamine—Confusional state—Paclitaxel—breast cancer	8.31e-05	0.00106	CcSEcCtD
Carbinoxamine—Nausea—Goserelin—breast cancer	8.13e-05	0.00104	CcSEcCtD
Carbinoxamine—Feeling abnormal—Gemcitabine—breast cancer	8.11e-05	0.00104	CcSEcCtD
Carbinoxamine—Dizziness—Vinorelbine—breast cancer	8.1e-05	0.00104	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Methotrexate—breast cancer	8.08e-05	0.00103	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Paclitaxel—breast cancer	8.07e-05	0.00103	CcSEcCtD
Carbinoxamine—Tachycardia—Paclitaxel—breast cancer	8.05e-05	0.00103	CcSEcCtD
Carbinoxamine—Urticaria—Mitoxantrone—breast cancer	8.03e-05	0.00103	CcSEcCtD
Carbinoxamine—Diarrhoea—Thiotepa—breast cancer	8.01e-05	0.00103	CcSEcCtD
Carbinoxamine—Feeling abnormal—Fluorouracil—breast cancer	7.98e-05	0.00102	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Paclitaxel—breast cancer	7.97e-05	0.00102	CcSEcCtD
Carbinoxamine—Drowsiness—Methotrexate—breast cancer	7.9e-05	0.00101	CcSEcCtD
Carbinoxamine—Anorexia—Paclitaxel—breast cancer	7.86e-05	0.00101	CcSEcCtD
Carbinoxamine—Vision blurred—Capecitabine—breast cancer	7.81e-05	0.001	CcSEcCtD
Carbinoxamine—Vomiting—Vinorelbine—breast cancer	7.79e-05	0.000998	CcSEcCtD
Carbinoxamine—Tremor—Capecitabine—breast cancer	7.77e-05	0.000994	CcSEcCtD
Carbinoxamine—Dizziness—Thiotepa—breast cancer	7.74e-05	0.000991	CcSEcCtD
Carbinoxamine—Hypotension—Paclitaxel—breast cancer	7.7e-05	0.000986	CcSEcCtD
Carbinoxamine—Urticaria—Fluorouracil—breast cancer	7.69e-05	0.000984	CcSEcCtD
Carbinoxamine—Headache—Vinorelbine—breast cancer	7.68e-05	0.000983	CcSEcCtD
Carbinoxamine—Pollakiuria—Epirubicin—breast cancer	7.66e-05	0.00098	CcSEcCtD
Carbinoxamine—Palpitations—Docetaxel—breast cancer	7.57e-05	0.000969	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Epirubicin—breast cancer	7.56e-05	0.000968	CcSEcCtD
Carbinoxamine—Insomnia—Paclitaxel—breast cancer	7.46e-05	0.000954	CcSEcCtD
Carbinoxamine—Vertigo—Capecitabine—breast cancer	7.45e-05	0.000953	CcSEcCtD
Carbinoxamine—Vomiting—Thiotepa—breast cancer	7.44e-05	0.000953	CcSEcCtD
Carbinoxamine—Convulsion—Docetaxel—breast cancer	7.42e-05	0.00095	CcSEcCtD
Carbinoxamine—Paraesthesia—Paclitaxel—breast cancer	7.4e-05	0.000948	CcSEcCtD
Carbinoxamine—Drowsiness—Epirubicin—breast cancer	7.39e-05	0.000946	CcSEcCtD
Carbinoxamine—Agranulocytosis—Methotrexate—breast cancer	7.37e-05	0.000943	CcSEcCtD
Carbinoxamine—Headache—Thiotepa—breast cancer	7.33e-05	0.000939	CcSEcCtD
Carbinoxamine—Somnolence—Paclitaxel—breast cancer	7.33e-05	0.000938	CcSEcCtD
Carbinoxamine—Palpitations—Capecitabine—breast cancer	7.32e-05	0.000938	CcSEcCtD
Carbinoxamine—Nausea—Vinorelbine—breast cancer	7.28e-05	0.000932	CcSEcCtD
Carbinoxamine—Dyspepsia—Paclitaxel—breast cancer	7.26e-05	0.000929	CcSEcCtD
Carbinoxamine—Asthenia—Irinotecan—breast cancer	7.25e-05	0.000928	CcSEcCtD
Carbinoxamine—Asthenia—Mitoxantrone—breast cancer	7.25e-05	0.000928	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Epirubicin—breast cancer	7.24e-05	0.000927	CcSEcCtD
Carbinoxamine—Decreased appetite—Paclitaxel—breast cancer	7.17e-05	0.000917	CcSEcCtD
Carbinoxamine—Fatigue—Paclitaxel—breast cancer	7.11e-05	0.00091	CcSEcCtD
Carbinoxamine—Pollakiuria—Doxorubicin—breast cancer	7.08e-05	0.000907	CcSEcCtD
Carbinoxamine—Asthenia—Gemcitabine—breast cancer	7.06e-05	0.000904	CcSEcCtD
Carbinoxamine—Constipation—Paclitaxel—breast cancer	7.05e-05	0.000902	CcSEcCtD
Carbinoxamine—Confusional state—Docetaxel—breast cancer	7.04e-05	0.000902	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Doxorubicin—breast cancer	7e-05	0.000896	CcSEcCtD
Carbinoxamine—Nausea—Thiotepa—breast cancer	6.95e-05	0.00089	CcSEcCtD
Carbinoxamine—Diarrhoea—Irinotecan—breast cancer	6.92e-05	0.000885	CcSEcCtD
Carbinoxamine—Diarrhoea—Mitoxantrone—breast cancer	6.92e-05	0.000885	CcSEcCtD
Carbinoxamine—Agranulocytosis—Epirubicin—breast cancer	6.9e-05	0.000883	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Docetaxel—breast cancer	6.84e-05	0.000876	CcSEcCtD
Carbinoxamine—Drowsiness—Doxorubicin—breast cancer	6.84e-05	0.000875	CcSEcCtD
Carbinoxamine—Confusional state—Capecitabine—breast cancer	6.82e-05	0.000873	CcSEcCtD
Carbinoxamine—Tachycardia—Docetaxel—breast cancer	6.82e-05	0.000873	CcSEcCtD
Carbinoxamine—Feeling abnormal—Paclitaxel—breast cancer	6.79e-05	0.00087	CcSEcCtD
Carbinoxamine—Diarrhoea—Gemcitabine—breast cancer	6.74e-05	0.000862	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Doxorubicin—breast cancer	6.7e-05	0.000858	CcSEcCtD
Carbinoxamine—Dizziness—Irinotecan—breast cancer	6.68e-05	0.000856	CcSEcCtD
Carbinoxamine—Anorexia—Docetaxel—breast cancer	6.66e-05	0.000853	CcSEcCtD
Carbinoxamine—Diarrhoea—Fluorouracil—breast cancer	6.62e-05	0.000848	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Capecitabine—breast cancer	6.62e-05	0.000848	CcSEcCtD
Carbinoxamine—Tinnitus—Methotrexate—breast cancer	6.61e-05	0.000846	CcSEcCtD
Carbinoxamine—Tachycardia—Capecitabine—breast cancer	6.6e-05	0.000845	CcSEcCtD
Carbinoxamine—Urticaria—Paclitaxel—breast cancer	6.55e-05	0.000838	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Capecitabine—breast cancer	6.54e-05	0.000837	CcSEcCtD
Carbinoxamine—Hypotension—Docetaxel—breast cancer	6.53e-05	0.000836	CcSEcCtD
Carbinoxamine—Anorexia—Capecitabine—breast cancer	6.45e-05	0.000825	CcSEcCtD
Carbinoxamine—Vomiting—Mitoxantrone—breast cancer	6.43e-05	0.000823	CcSEcCtD
Carbinoxamine—Vomiting—Irinotecan—breast cancer	6.43e-05	0.000823	CcSEcCtD
Carbinoxamine—Dizziness—Fluorouracil—breast cancer	6.4e-05	0.000819	CcSEcCtD
Carbinoxamine—Agranulocytosis—Doxorubicin—breast cancer	6.38e-05	0.000817	CcSEcCtD
Carbinoxamine—Chills—Methotrexate—breast cancer	6.36e-05	0.000814	CcSEcCtD
Carbinoxamine—Headache—Irinotecan—breast cancer	6.33e-05	0.000811	CcSEcCtD
Carbinoxamine—Headache—Mitoxantrone—breast cancer	6.33e-05	0.000811	CcSEcCtD
Carbinoxamine—Hypotension—Capecitabine—breast cancer	6.32e-05	0.000809	CcSEcCtD
Carbinoxamine—Insomnia—Docetaxel—breast cancer	6.32e-05	0.000809	CcSEcCtD
Carbinoxamine—Paraesthesia—Docetaxel—breast cancer	6.27e-05	0.000803	CcSEcCtD
Carbinoxamine—Vomiting—Gemcitabine—breast cancer	6.26e-05	0.000801	CcSEcCtD
Carbinoxamine—Somnolence—Docetaxel—breast cancer	6.21e-05	0.000795	CcSEcCtD
Carbinoxamine—Tinnitus—Epirubicin—breast cancer	6.18e-05	0.000792	CcSEcCtD
Carbinoxamine—Headache—Gemcitabine—breast cancer	6.17e-05	0.00079	CcSEcCtD
Carbinoxamine—Vomiting—Fluorouracil—breast cancer	6.15e-05	0.000788	CcSEcCtD
Carbinoxamine—Dyspepsia—Docetaxel—breast cancer	6.15e-05	0.000787	CcSEcCtD
Carbinoxamine—Insomnia—Capecitabine—breast cancer	6.12e-05	0.000783	CcSEcCtD
Carbinoxamine—Paraesthesia—Capecitabine—breast cancer	6.07e-05	0.000778	CcSEcCtD
Carbinoxamine—Decreased appetite—Docetaxel—breast cancer	6.07e-05	0.000778	CcSEcCtD
Carbinoxamine—Headache—Fluorouracil—breast cancer	6.06e-05	0.000776	CcSEcCtD
Carbinoxamine—Fatigue—Docetaxel—breast cancer	6.02e-05	0.000771	CcSEcCtD
Carbinoxamine—Nausea—Mitoxantrone—breast cancer	6e-05	0.000769	CcSEcCtD
Carbinoxamine—Nausea—Irinotecan—breast cancer	6e-05	0.000769	CcSEcCtD
Carbinoxamine—Constipation—Docetaxel—breast cancer	5.97e-05	0.000765	CcSEcCtD
Carbinoxamine—Dyspepsia—Capecitabine—breast cancer	5.95e-05	0.000762	CcSEcCtD
Carbinoxamine—Chills—Epirubicin—breast cancer	5.95e-05	0.000762	CcSEcCtD
Carbinoxamine—Asthenia—Paclitaxel—breast cancer	5.91e-05	0.000757	CcSEcCtD
Carbinoxamine—Decreased appetite—Capecitabine—breast cancer	5.88e-05	0.000753	CcSEcCtD
Carbinoxamine—Nausea—Gemcitabine—breast cancer	5.85e-05	0.000749	CcSEcCtD
Carbinoxamine—Fatigue—Capecitabine—breast cancer	5.83e-05	0.000747	CcSEcCtD
Carbinoxamine—Vision blurred—Methotrexate—breast cancer	5.82e-05	0.000744	CcSEcCtD
Carbinoxamine—Constipation—Capecitabine—breast cancer	5.78e-05	0.000741	CcSEcCtD
Carbinoxamine—Brompheniramine—CYP2D6—breast cancer	5.78e-05	0.0414	CrCbGaD
Carbinoxamine—Feeling abnormal—Docetaxel—breast cancer	5.76e-05	0.000737	CcSEcCtD
Carbinoxamine—Nausea—Fluorouracil—breast cancer	5.75e-05	0.000736	CcSEcCtD
Carbinoxamine—Tinnitus—Doxorubicin—breast cancer	5.72e-05	0.000733	CcSEcCtD
Carbinoxamine—Chlorphenamine—CYP2D6—breast cancer	5.67e-05	0.0406	CrCbGaD
Carbinoxamine—Tension—Epirubicin—breast cancer	5.67e-05	0.000725	CcSEcCtD
Carbinoxamine—Diphenhydramine—PTGS1—breast cancer	5.66e-05	0.0405	CrCbGaD
Carbinoxamine—Diarrhoea—Paclitaxel—breast cancer	5.64e-05	0.000722	CcSEcCtD
Carbinoxamine—Nervousness—Epirubicin—breast cancer	5.61e-05	0.000718	CcSEcCtD
Carbinoxamine—Feeling abnormal—Capecitabine—breast cancer	5.57e-05	0.000714	CcSEcCtD
Carbinoxamine—Vertigo—Methotrexate—breast cancer	5.54e-05	0.00071	CcSEcCtD
Carbinoxamine—Chills—Doxorubicin—breast cancer	5.51e-05	0.000705	CcSEcCtD
Carbinoxamine—Dizziness—Paclitaxel—breast cancer	5.45e-05	0.000698	CcSEcCtD
Carbinoxamine—Vision blurred—Epirubicin—breast cancer	5.44e-05	0.000697	CcSEcCtD
Carbinoxamine—Urticaria—Capecitabine—breast cancer	5.37e-05	0.000688	CcSEcCtD
Carbinoxamine—Convulsion—Methotrexate—breast cancer	5.35e-05	0.000684	CcSEcCtD
Carbinoxamine—Chlorpromazine—BCHE—breast cancer	5.33e-05	0.0381	CrCbGaD
Carbinoxamine—Agitation—Epirubicin—breast cancer	5.31e-05	0.000679	CcSEcCtD
Carbinoxamine—Tension—Doxorubicin—breast cancer	5.24e-05	0.000671	CcSEcCtD
Carbinoxamine—Vomiting—Paclitaxel—breast cancer	5.24e-05	0.000671	CcSEcCtD
Carbinoxamine—Nervousness—Doxorubicin—breast cancer	5.19e-05	0.000664	CcSEcCtD
Carbinoxamine—Vertigo—Epirubicin—breast cancer	5.19e-05	0.000664	CcSEcCtD
Carbinoxamine—Headache—Paclitaxel—breast cancer	5.16e-05	0.000661	CcSEcCtD
Carbinoxamine—Palpitations—Epirubicin—breast cancer	5.1e-05	0.000653	CcSEcCtD
Carbinoxamine—Confusional state—Methotrexate—breast cancer	5.08e-05	0.00065	CcSEcCtD
Carbinoxamine—Vision blurred—Doxorubicin—breast cancer	5.04e-05	0.000645	CcSEcCtD
Carbinoxamine—Asthenia—Docetaxel—breast cancer	5.01e-05	0.000642	CcSEcCtD
Carbinoxamine—Convulsion—Epirubicin—breast cancer	5e-05	0.00064	CcSEcCtD
Carbinoxamine—Brompheniramine—CYP3A4—breast cancer	4.96e-05	0.0355	CrCbGaD
Carbinoxamine—Thrombocytopenia—Methotrexate—breast cancer	4.93e-05	0.000631	CcSEcCtD
Carbinoxamine—Agitation—Doxorubicin—breast cancer	4.91e-05	0.000629	CcSEcCtD
Carbinoxamine—Nausea—Paclitaxel—breast cancer	4.9e-05	0.000627	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Methotrexate—breast cancer	4.87e-05	0.000623	CcSEcCtD
Carbinoxamine—Chlorphenamine—CYP3A4—breast cancer	4.87e-05	0.0349	CrCbGaD
Carbinoxamine—Asthenia—Capecitabine—breast cancer	4.85e-05	0.000621	CcSEcCtD
Carbinoxamine—Vertigo—Doxorubicin—breast cancer	4.8e-05	0.000615	CcSEcCtD
Carbinoxamine—Anorexia—Methotrexate—breast cancer	4.8e-05	0.000615	CcSEcCtD
Carbinoxamine—Diarrhoea—Docetaxel—breast cancer	4.78e-05	0.000612	CcSEcCtD
Carbinoxamine—Confusional state—Epirubicin—breast cancer	4.75e-05	0.000608	CcSEcCtD
Carbinoxamine—Palpitations—Doxorubicin—breast cancer	4.72e-05	0.000604	CcSEcCtD
Carbinoxamine—Hypotension—Methotrexate—breast cancer	4.71e-05	0.000602	CcSEcCtD
Carbinoxamine—Convulsion—Doxorubicin—breast cancer	4.63e-05	0.000593	CcSEcCtD
Carbinoxamine—Diarrhoea—Capecitabine—breast cancer	4.63e-05	0.000593	CcSEcCtD
Carbinoxamine—Dizziness—Docetaxel—breast cancer	4.62e-05	0.000591	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Epirubicin—breast cancer	4.61e-05	0.000591	CcSEcCtD
Carbinoxamine—Tachycardia—Epirubicin—breast cancer	4.6e-05	0.000589	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Epirubicin—breast cancer	4.56e-05	0.000583	CcSEcCtD
Carbinoxamine—Insomnia—Methotrexate—breast cancer	4.55e-05	0.000583	CcSEcCtD
Carbinoxamine—Paraesthesia—Methotrexate—breast cancer	4.52e-05	0.000579	CcSEcCtD
Carbinoxamine—Anorexia—Epirubicin—breast cancer	4.49e-05	0.000575	CcSEcCtD
Carbinoxamine—Somnolence—Methotrexate—breast cancer	4.48e-05	0.000573	CcSEcCtD
Carbinoxamine—Dizziness—Capecitabine—breast cancer	4.47e-05	0.000573	CcSEcCtD
Carbinoxamine—Vomiting—Docetaxel—breast cancer	4.44e-05	0.000569	CcSEcCtD
Carbinoxamine—Dyspepsia—Methotrexate—breast cancer	4.43e-05	0.000567	CcSEcCtD
Carbinoxamine—Hypotension—Epirubicin—breast cancer	4.4e-05	0.000564	CcSEcCtD
Carbinoxamine—Confusional state—Doxorubicin—breast cancer	4.4e-05	0.000563	CcSEcCtD
Carbinoxamine—Decreased appetite—Methotrexate—breast cancer	4.38e-05	0.00056	CcSEcCtD
Carbinoxamine—Headache—Docetaxel—breast cancer	4.38e-05	0.00056	CcSEcCtD
Carbinoxamine—Fatigue—Methotrexate—breast cancer	4.34e-05	0.000556	CcSEcCtD
Carbinoxamine—Vomiting—Capecitabine—breast cancer	4.3e-05	0.000551	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Doxorubicin—breast cancer	4.27e-05	0.000547	CcSEcCtD
Carbinoxamine—Insomnia—Epirubicin—breast cancer	4.26e-05	0.000546	CcSEcCtD
Carbinoxamine—Clomipramine—CYP2D6—breast cancer	4.26e-05	0.0305	CrCbGaD
Carbinoxamine—Tachycardia—Doxorubicin—breast cancer	4.26e-05	0.000545	CcSEcCtD
Carbinoxamine—Headache—Capecitabine—breast cancer	4.24e-05	0.000543	CcSEcCtD
Carbinoxamine—Paraesthesia—Epirubicin—breast cancer	4.23e-05	0.000542	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Doxorubicin—breast cancer	4.22e-05	0.00054	CcSEcCtD
Carbinoxamine—Somnolence—Epirubicin—breast cancer	4.19e-05	0.000536	CcSEcCtD
Carbinoxamine—Anorexia—Doxorubicin—breast cancer	4.16e-05	0.000532	CcSEcCtD
Carbinoxamine—Nausea—Docetaxel—breast cancer	4.15e-05	0.000531	CcSEcCtD
Carbinoxamine—Feeling abnormal—Methotrexate—breast cancer	4.15e-05	0.000531	CcSEcCtD
Carbinoxamine—Dyspepsia—Epirubicin—breast cancer	4.15e-05	0.000531	CcSEcCtD
Carbinoxamine—Decreased appetite—Epirubicin—breast cancer	4.1e-05	0.000524	CcSEcCtD
Carbinoxamine—Hypotension—Doxorubicin—breast cancer	4.07e-05	0.000522	CcSEcCtD
Carbinoxamine—Fatigue—Epirubicin—breast cancer	4.06e-05	0.00052	CcSEcCtD
Carbinoxamine—Constipation—Epirubicin—breast cancer	4.03e-05	0.000516	CcSEcCtD
Carbinoxamine—Nausea—Capecitabine—breast cancer	4.02e-05	0.000514	CcSEcCtD
Carbinoxamine—Urticaria—Methotrexate—breast cancer	4e-05	0.000512	CcSEcCtD
Carbinoxamine—Insomnia—Doxorubicin—breast cancer	3.94e-05	0.000505	CcSEcCtD
Carbinoxamine—Paraesthesia—Doxorubicin—breast cancer	3.92e-05	0.000501	CcSEcCtD
Carbinoxamine—Feeling abnormal—Epirubicin—breast cancer	3.88e-05	0.000497	CcSEcCtD
Carbinoxamine—Somnolence—Doxorubicin—breast cancer	3.88e-05	0.000496	CcSEcCtD
Carbinoxamine—Diphenhydramine—CYP2D6—breast cancer	3.85e-05	0.0276	CrCbGaD
Carbinoxamine—Dyspepsia—Doxorubicin—breast cancer	3.84e-05	0.000491	CcSEcCtD
Carbinoxamine—Decreased appetite—Doxorubicin—breast cancer	3.79e-05	0.000485	CcSEcCtD
Carbinoxamine—Fatigue—Doxorubicin—breast cancer	3.76e-05	0.000481	CcSEcCtD
Carbinoxamine—Urticaria—Epirubicin—breast cancer	3.74e-05	0.000479	CcSEcCtD
Carbinoxamine—Constipation—Doxorubicin—breast cancer	3.73e-05	0.000477	CcSEcCtD
Carbinoxamine—Clomipramine—CYP3A4—breast cancer	3.66e-05	0.0262	CrCbGaD
Carbinoxamine—Asthenia—Methotrexate—breast cancer	3.61e-05	0.000463	CcSEcCtD
Carbinoxamine—Feeling abnormal—Doxorubicin—breast cancer	3.59e-05	0.00046	CcSEcCtD
Carbinoxamine—Urticaria—Doxorubicin—breast cancer	3.46e-05	0.000443	CcSEcCtD
Carbinoxamine—Diarrhoea—Methotrexate—breast cancer	3.45e-05	0.000441	CcSEcCtD
Carbinoxamine—Asthenia—Epirubicin—breast cancer	3.38e-05	0.000433	CcSEcCtD
Carbinoxamine—Dizziness—Methotrexate—breast cancer	3.33e-05	0.000426	CcSEcCtD
Carbinoxamine—Diarrhoea—Epirubicin—breast cancer	3.22e-05	0.000413	CcSEcCtD
Carbinoxamine—Vomiting—Methotrexate—breast cancer	3.2e-05	0.00041	CcSEcCtD
Carbinoxamine—Clomipramine—ALB—breast cancer	3.19e-05	0.0228	CrCbGaD
Carbinoxamine—Headache—Methotrexate—breast cancer	3.15e-05	0.000404	CcSEcCtD
Carbinoxamine—Asthenia—Doxorubicin—breast cancer	3.13e-05	0.000401	CcSEcCtD
Carbinoxamine—Orphenadrine—CYP3A4—breast cancer	3.12e-05	0.0224	CrCbGaD
Carbinoxamine—Dizziness—Epirubicin—breast cancer	3.12e-05	0.000399	CcSEcCtD
Carbinoxamine—Clomipramine—ABCB1—breast cancer	3.04e-05	0.0218	CrCbGaD
Carbinoxamine—Chlorprothixene—ABCB1—breast cancer	3.03e-05	0.0217	CrCbGaD
Carbinoxamine—Vomiting—Epirubicin—breast cancer	3e-05	0.000384	CcSEcCtD
Carbinoxamine—Nausea—Methotrexate—breast cancer	2.99e-05	0.000383	CcSEcCtD
Carbinoxamine—Diarrhoea—Doxorubicin—breast cancer	2.98e-05	0.000382	CcSEcCtD
Carbinoxamine—Headache—Epirubicin—breast cancer	2.95e-05	0.000378	CcSEcCtD
Carbinoxamine—Chlorpromazine—CYP2D6—breast cancer	2.92e-05	0.0209	CrCbGaD
Carbinoxamine—Dizziness—Doxorubicin—breast cancer	2.88e-05	0.000369	CcSEcCtD
Carbinoxamine—Nausea—Epirubicin—breast cancer	2.8e-05	0.000358	CcSEcCtD
Carbinoxamine—Vomiting—Doxorubicin—breast cancer	2.77e-05	0.000355	CcSEcCtD
Carbinoxamine—Headache—Doxorubicin—breast cancer	2.73e-05	0.00035	CcSEcCtD
Carbinoxamine—Nausea—Doxorubicin—breast cancer	2.59e-05	0.000332	CcSEcCtD
Carbinoxamine—Chlorpromazine—CYP3A4—breast cancer	2.51e-05	0.018	CrCbGaD
Carbinoxamine—Chlorpromazine—ALB—breast cancer	2.19e-05	0.0157	CrCbGaD
Carbinoxamine—Chlorpromazine—ABCB1—breast cancer	2.09e-05	0.0149	CrCbGaD
Carbinoxamine—CYP2D6—Metabolism—SLC2A1—breast cancer	3.1e-06	6.8e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NQO1—breast cancer	3.1e-06	6.8e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ITPR1—breast cancer	3.1e-06	6.79e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CXCL8—breast cancer	3.09e-06	6.79e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NCOA1—breast cancer	3.08e-06	6.76e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ERBB3—breast cancer	3.07e-06	6.74e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NQO1—breast cancer	3.07e-06	6.74e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SLC2A1—breast cancer	3.07e-06	6.74e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGFR2—breast cancer	3.07e-06	6.73e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—STK11—breast cancer	3.04e-06	6.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP19A1—breast cancer	3.04e-06	6.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP3A4—breast cancer	3.02e-06	6.63e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—MTHFR—breast cancer	3.02e-06	6.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.01e-06	6.6e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP3A4—breast cancer	3e-06	6.57e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.98e-06	6.54e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ABCB1—breast cancer	2.98e-06	6.54e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP1B1—breast cancer	2.97e-06	6.52e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—MTHFR—breast cancer	2.96e-06	6.49e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL2—breast cancer	2.96e-06	6.49e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TERT—breast cancer	2.95e-06	6.46e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP1B1—breast cancer	2.95e-06	6.46e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—TYMS—breast cancer	2.93e-06	6.42e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.91e-06	6.39e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.89e-06	6.35e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—NCOR1—breast cancer	2.89e-06	6.35e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTM1—breast cancer	2.89e-06	6.35e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.89e-06	6.34e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGFR1—breast cancer	2.86e-06	6.27e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.85e-06	6.25e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NCOA1—breast cancer	2.83e-06	6.22e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—COMT—breast cancer	2.82e-06	6.19e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HIF1A—breast cancer	2.82e-06	6.18e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTP1—breast cancer	2.81e-06	6.16e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NCOA1—breast cancer	2.81e-06	6.16e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—STK11—breast cancer	2.79e-06	6.13e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP19A1—breast cancer	2.79e-06	6.13e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CAV1—breast cancer	2.79e-06	6.11e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HMOX1—breast cancer	2.77e-06	6.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GPX1—breast cancer	2.77e-06	6.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP19A1—breast cancer	2.77e-06	6.07e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—STK11—breast cancer	2.77e-06	6.07e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ITPR1—breast cancer	2.76e-06	6.06e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MED12—breast cancer	2.76e-06	6.05e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—DPYD—breast cancer	2.76e-06	6.05e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LEP—breast cancer	2.75e-06	6.03e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP1A1—breast cancer	2.74e-06	6.02e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CAV1—breast cancer	2.73e-06	5.98e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CAV1—breast cancer	2.72e-06	5.98e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ERCC2—breast cancer	2.72e-06	5.97e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALDOA—breast cancer	2.71e-06	5.95e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KDR—breast cancer	2.69e-06	5.91e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ABCB1—breast cancer	2.66e-06	5.83e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NCOA3—breast cancer	2.63e-06	5.78e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ESR1—breast cancer	2.63e-06	5.76e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC2A2—breast cancer	2.62e-06	5.74e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—TYMS—breast cancer	2.61e-06	5.73e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.6e-06	5.7e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—COMT—breast cancer	2.6e-06	5.7e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FN1—breast cancer	2.59e-06	5.69e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTP1—breast cancer	2.58e-06	5.67e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NCOR1—breast cancer	2.58e-06	5.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTM1—breast cancer	2.58e-06	5.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.58e-06	5.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—COMT—breast cancer	2.57e-06	5.65e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCG2—breast cancer	2.56e-06	5.62e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CPT1A—breast cancer	2.56e-06	5.62e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTR—breast cancer	2.56e-06	5.62e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NFKBIA—breast cancer	2.56e-06	5.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTP1—breast cancer	2.56e-06	5.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—MTHFR—breast cancer	2.56e-06	5.61e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HMOX1—breast cancer	2.55e-06	5.59e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ITPR1—breast cancer	2.54e-06	5.58e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOTCH1—breast cancer	2.54e-06	5.57e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CG—breast cancer	2.54e-06	5.57e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HMOX1—breast cancer	2.53e-06	5.54e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ITPR1—breast cancer	2.52e-06	5.53e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HPGDS—breast cancer	2.51e-06	5.51e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HBA1—breast cancer	2.5e-06	5.48e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CG—breast cancer	2.49e-06	5.45e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CG—breast cancer	2.48e-06	5.44e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KIT—breast cancer	2.48e-06	5.44e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APC—breast cancer	2.48e-06	5.44e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GPX1—breast cancer	2.47e-06	5.42e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EGF—breast cancer	2.45e-06	5.38e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP1A1—breast cancer	2.45e-06	5.37e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ABCB1—breast cancer	2.45e-06	5.37e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ACHE—breast cancer	2.44e-06	5.35e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTT1—breast cancer	2.44e-06	5.35e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ERCC2—breast cancer	2.43e-06	5.33e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ABCB1—breast cancer	2.43e-06	5.32e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—TYMS—breast cancer	2.4e-06	5.27e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—TYMS—breast cancer	2.38e-06	5.22e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAPK3—breast cancer	2.38e-06	5.21e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NCOR1—breast cancer	2.37e-06	5.21e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.37e-06	5.21e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTM1—breast cancer	2.37e-06	5.21e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CAV1—breast cancer	2.36e-06	5.17e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NCOR1—breast cancer	2.35e-06	5.16e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTM1—breast cancer	2.35e-06	5.16e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.35e-06	5.16e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—BRAF—breast cancer	2.33e-06	5.12e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP17A1—breast cancer	2.31e-06	5.06e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ENO1—breast cancer	2.28e-06	5.01e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS1—breast cancer	2.28e-06	5.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—MTHFR—breast cancer	2.28e-06	5.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GPX1—breast cancer	2.27e-06	4.99e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF1—breast cancer	2.27e-06	4.98e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT2—breast cancer	2.27e-06	4.98e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—EGFR—breast cancer	2.26e-06	4.96e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GPX1—breast cancer	2.25e-06	4.95e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.25e-06	4.94e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP1A1—breast cancer	2.25e-06	4.94e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP2D6—breast cancer	2.24e-06	4.91e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ERCC2—breast cancer	2.23e-06	4.9e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP1A1—breast cancer	2.23e-06	4.9e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CD—breast cancer	2.23e-06	4.89e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ERCC2—breast cancer	2.21e-06	4.86e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ALB—breast cancer	2.2e-06	4.83e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NCOA2—breast cancer	2.2e-06	4.82e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CD—breast cancer	2.18e-06	4.79e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CD—breast cancer	2.18e-06	4.79e-05	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	2.16e-06	4.74e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SERPINE1—breast cancer	2.16e-06	4.73e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ALB—breast cancer	2.16e-06	4.73e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CG—breast cancer	2.15e-06	4.71e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—KRAS—breast cancer	2.14e-06	4.69e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—FASN—breast cancer	2.13e-06	4.68e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—BCHE—breast cancer	2.12e-06	4.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—NOS3—breast cancer	2.11e-06	4.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CAV1—breast cancer	2.1e-06	4.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—MTHFR—breast cancer	2.1e-06	4.6e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC5A5—breast cancer	2.1e-06	4.6e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—MTHFR—breast cancer	2.08e-06	4.56e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—NOS3—breast cancer	2.06e-06	4.53e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOS3—breast cancer	2.06e-06	4.52e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NQO1—breast cancer	2.03e-06	4.44e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC2A1—breast cancer	2.03e-06	4.44e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.01e-06	4.41e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	1.96e-06	4.3e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MDM2—breast cancer	1.95e-06	4.29e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RAF1—breast cancer	1.95e-06	4.27e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CB—breast cancer	1.94e-06	4.26e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.94e-06	4.26e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RELA—breast cancer	1.94e-06	4.25e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CAV1—breast cancer	1.94e-06	4.25e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ERBB2—breast cancer	1.93e-06	4.23e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTGS2—breast cancer	1.93e-06	4.23e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CAV1—breast cancer	1.92e-06	4.21e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CG—breast cancer	1.92e-06	4.21e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.9e-06	4.18e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CB—breast cancer	1.9e-06	4.18e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MTOR—breast cancer	1.9e-06	4.17e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CB—breast cancer	1.9e-06	4.17e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CD—breast cancer	1.89e-06	4.14e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTGS2—breast cancer	1.89e-06	4.14e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ALB—breast cancer	1.86e-06	4.09e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NCOA1—breast cancer	1.85e-06	4.06e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.83e-06	4.02e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CXCL8—breast cancer	1.83e-06	4.01e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.83e-06	4.01e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—STK11—breast cancer	1.83e-06	4.01e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—HRAS—breast cancer	1.82e-06	3.98e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CDKN1B—breast cancer	1.78e-06	3.91e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—NOS3—breast cancer	1.78e-06	3.91e-05	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—AKT1—breast cancer	1.77e-06	3.87e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.76e-06	3.87e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CASP3—breast cancer	1.75e-06	3.84e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CG—breast cancer	1.75e-06	3.83e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL2—breast cancer	1.75e-06	3.83e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6—breast cancer	1.74e-06	3.81e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCND1—breast cancer	1.7e-06	3.73e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—JUN—breast cancer	1.7e-06	3.73e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—COMT—breast cancer	1.7e-06	3.72e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTP1—breast cancer	1.69e-06	3.71e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CTNNB1—breast cancer	1.69e-06	3.7e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CD—breast cancer	1.69e-06	3.7e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTEN—breast cancer	1.68e-06	3.69e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMOX1—breast cancer	1.67e-06	3.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALB—breast cancer	1.66e-06	3.65e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ITPR1—breast cancer	1.66e-06	3.65e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MMP9—breast cancer	1.65e-06	3.63e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CDKN1A—breast cancer	1.65e-06	3.61e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CB—breast cancer	1.65e-06	3.61e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTEN—breast cancer	1.65e-06	3.61e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PTEN—breast cancer	1.64e-06	3.6e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTGS2—breast cancer	1.63e-06	3.58e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK8—breast cancer	1.61e-06	3.53e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—AKT1—breast cancer	1.6e-06	3.52e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCB1—breast cancer	1.6e-06	3.51e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NOS3—breast cancer	1.59e-06	3.49e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—TYMS—breast cancer	1.57e-06	3.45e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NCOR1—breast cancer	1.55e-06	3.41e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.55e-06	3.41e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTM1—breast cancer	1.55e-06	3.41e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.55e-06	3.4e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CD—breast cancer	1.54e-06	3.37e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALB—breast cancer	1.53e-06	3.36e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SRC—breast cancer	1.52e-06	3.34e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALB—breast cancer	1.52e-06	3.33e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GPX1—breast cancer	1.49e-06	3.26e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—breast cancer	1.48e-06	3.26e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.47e-06	3.23e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—STAT3—breast cancer	1.47e-06	3.22e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CB—breast cancer	1.47e-06	3.22e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NOS3—breast cancer	1.46e-06	3.21e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ERCC2—breast cancer	1.46e-06	3.2e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTGS2—breast cancer	1.46e-06	3.19e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NOS3—breast cancer	1.45e-06	3.18e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTEN—breast cancer	1.42e-06	3.12e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK3—breast cancer	1.4e-06	3.08e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTHFR—breast cancer	1.37e-06	3.01e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MYC—breast cancer	1.37e-06	3e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TGFB1—breast cancer	1.36e-06	2.99e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.35e-06	2.96e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CB—breast cancer	1.34e-06	2.94e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTGS2—breast cancer	1.34e-06	2.94e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EGFR—breast cancer	1.34e-06	2.93e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTGS2—breast cancer	1.33e-06	2.91e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTEN—breast cancer	1.27e-06	2.78e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CAV1—breast cancer	1.27e-06	2.78e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KRAS—breast cancer	1.26e-06	2.77e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CA—breast cancer	1.19e-06	2.6e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTEN—breast cancer	1.17e-06	2.56e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CA—breast cancer	1.16e-06	2.55e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.16e-06	2.54e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTEN—breast cancer	1.16e-06	2.54e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.15e-06	2.53e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TP53—breast cancer	1.12e-06	2.46e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HRAS—breast cancer	1.07e-06	2.35e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6—breast cancer	1.03e-06	2.25e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.01e-06	2.22e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CA—breast cancer	1e-06	2.2e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALB—breast cancer	1e-06	2.19e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AKT1—breast cancer	9.68e-07	2.12e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NOS3—breast cancer	9.57e-07	2.1e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AKT1—breast cancer	9.48e-07	2.08e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT1—breast cancer	9.47e-07	2.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CA—breast cancer	8.96e-07	1.96e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CB—breast cancer	8.83e-07	1.94e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS2—breast cancer	8.75e-07	1.92e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CA—breast cancer	8.24e-07	1.81e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AKT1—breast cancer	8.2e-07	1.8e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CA—breast cancer	8.17e-07	1.79e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTEN—breast cancer	7.63e-07	1.67e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AKT1—breast cancer	7.32e-07	1.6e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKT1—breast cancer	6.73e-07	1.48e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKT1—breast cancer	6.67e-07	1.46e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CA—breast cancer	5.39e-07	1.18e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKT1—breast cancer	4.4e-07	9.65e-06	CbGpPWpGaD
